The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Aminoglycoside Drug Market Research Report 2025
Synopsis
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
The global Aminoglycoside Drug market was valued at US$ 1056 million in 2023 and is anticipated to reach US$ 1102.5 million by 2030, witnessing a CAGR of 0.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Aminoglycoside Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoglycoside Drug.
Report Scope
The Aminoglycoside Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aminoglycoside Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aminoglycoside Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jemicare
Teva
Novartis Pharmaceuticals
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
FRESENIUS KABI
Sun Pharma
Hikma
Lannett Company
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Segment by Application
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aminoglycoside Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aminoglycoside Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
The global Aminoglycoside Drug market was valued at US$ 1056 million in 2023 and is anticipated to reach US$ 1102.5 million by 2030, witnessing a CAGR of 0.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Aminoglycoside Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoglycoside Drug.
Report Scope
The Aminoglycoside Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aminoglycoside Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aminoglycoside Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jemicare
Teva
Novartis Pharmaceuticals
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
FRESENIUS KABI
Sun Pharma
Hikma
Lannett Company
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Segment by Application
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aminoglycoside Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aminoglycoside Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Aminoglycoside Drug Market Overview
1.1 Product Overview and Scope of Aminoglycoside Drug
1.2 Aminoglycoside Drug Segment by Type
1.2.1 Global Aminoglycoside Drug Market Value Comparison by Type (2024-2030)
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Etimicin
1.2.7 Others
1.3 Aminoglycoside Drug Segment by Application
1.3.1 Global Aminoglycoside Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Aminoglycoside Drug Market Size Estimates and Forecasts
1.4.1 Global Aminoglycoside Drug Revenue 2019-2030
1.4.2 Global Aminoglycoside Drug Sales 2019-2030
1.4.3 Global Aminoglycoside Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Aminoglycoside Drug Market Competition by Manufacturers
2.1 Global Aminoglycoside Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Aminoglycoside Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Aminoglycoside Drug Average Price by Manufacturers (2019-2024)
2.4 Global Aminoglycoside Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aminoglycoside Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aminoglycoside Drug, Product Type & Application
2.7 Aminoglycoside Drug Market Competitive Situation and Trends
2.7.1 Aminoglycoside Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aminoglycoside Drug Players Market Share by Revenue
2.7.3 Global Aminoglycoside Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aminoglycoside Drug Retrospective Market Scenario by Region
3.1 Global Aminoglycoside Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Aminoglycoside Drug Global Aminoglycoside Drug Sales by Region: 2019-2030
3.2.1 Global Aminoglycoside Drug Sales by Region: 2019-2024
3.2.2 Global Aminoglycoside Drug Sales by Region: 2025-2030
3.3 Global Aminoglycoside Drug Global Aminoglycoside Drug Revenue by Region: 2019-2030
3.3.1 Global Aminoglycoside Drug Revenue by Region: 2019-2024
3.3.2 Global Aminoglycoside Drug Revenue by Region: 2025-2030
3.4 North America Aminoglycoside Drug Market Facts & Figures by Country
3.4.1 North America Aminoglycoside Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Aminoglycoside Drug Sales by Country (2019-2030)
3.4.3 North America Aminoglycoside Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aminoglycoside Drug Market Facts & Figures by Country
3.5.1 Europe Aminoglycoside Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Aminoglycoside Drug Sales by Country (2019-2030)
3.5.3 Europe Aminoglycoside Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aminoglycoside Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Aminoglycoside Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Aminoglycoside Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Aminoglycoside Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aminoglycoside Drug Market Facts & Figures by Country
3.7.1 Latin America Aminoglycoside Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Aminoglycoside Drug Sales by Country (2019-2030)
3.7.3 Latin America Aminoglycoside Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aminoglycoside Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Aminoglycoside Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Aminoglycoside Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Aminoglycoside Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Aminoglycoside Drug Sales by Type (2019-2030)
4.1.1 Global Aminoglycoside Drug Sales by Type (2019-2024)
4.1.2 Global Aminoglycoside Drug Sales by Type (2025-2030)
4.1.3 Global Aminoglycoside Drug Sales Market Share by Type (2019-2030)
4.2 Global Aminoglycoside Drug Revenue by Type (2019-2030)
4.2.1 Global Aminoglycoside Drug Revenue by Type (2019-2024)
4.2.2 Global Aminoglycoside Drug Revenue by Type (2025-2030)
4.2.3 Global Aminoglycoside Drug Revenue Market Share by Type (2019-2030)
4.3 Global Aminoglycoside Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Aminoglycoside Drug Sales by Application (2019-2030)
5.1.1 Global Aminoglycoside Drug Sales by Application (2019-2024)
5.1.2 Global Aminoglycoside Drug Sales by Application (2025-2030)
5.1.3 Global Aminoglycoside Drug Sales Market Share by Application (2019-2030)
5.2 Global Aminoglycoside Drug Revenue by Application (2019-2030)
5.2.1 Global Aminoglycoside Drug Revenue by Application (2019-2024)
5.2.2 Global Aminoglycoside Drug Revenue by Application (2025-2030)
5.2.3 Global Aminoglycoside Drug Revenue Market Share by Application (2019-2030)
5.3 Global Aminoglycoside Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Jemicare
6.1.1 Jemicare Corporation Information
6.1.2 Jemicare Description and Business Overview
6.1.3 Jemicare Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jemicare Aminoglycoside Drug Product Portfolio
6.1.5 Jemicare Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Aminoglycoside Drug Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Novartis Pharmaceuticals
6.3.1 Novartis Pharmaceuticals Corporation Information
6.3.2 Novartis Pharmaceuticals Description and Business Overview
6.3.3 Novartis Pharmaceuticals Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Pharmaceuticals Aminoglycoside Drug Product Portfolio
6.3.5 Novartis Pharmaceuticals Recent Developments/Updates
6.4 Fangyuan-pharma
6.4.1 Fangyuan-pharma Corporation Information
6.4.2 Fangyuan-pharma Description and Business Overview
6.4.3 Fangyuan-pharma Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fangyuan-pharma Aminoglycoside Drug Product Portfolio
6.4.5 Fangyuan-pharma Recent Developments/Updates
6.5 Aike Pharmaceutical
6.5.1 Aike Pharmaceutical Corporation Information
6.5.2 Aike Pharmaceutical Description and Business Overview
6.5.3 Aike Pharmaceutical Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aike Pharmaceutical Aminoglycoside Drug Product Portfolio
6.5.5 Aike Pharmaceutical Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Aminoglycoside Drug Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Aminoglycoside Drug Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 FRESENIUS KABI
6.8.1 FRESENIUS KABI Corporation Information
6.8.2 FRESENIUS KABI Description and Business Overview
6.8.3 FRESENIUS KABI Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 FRESENIUS KABI Aminoglycoside Drug Product Portfolio
6.8.5 FRESENIUS KABI Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Corporation Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharma Aminoglycoside Drug Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Hikma
6.10.1 Hikma Corporation Information
6.10.2 Hikma Description and Business Overview
6.10.3 Hikma Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hikma Aminoglycoside Drug Product Portfolio
6.10.5 Hikma Recent Developments/Updates
6.11 Lannett Company
6.11.1 Lannett Company Corporation Information
6.11.2 Lannett Company Aminoglycoside Drug Description and Business Overview
6.11.3 Lannett Company Aminoglycoside Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lannett Company Aminoglycoside Drug Product Portfolio
6.11.5 Lannett Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aminoglycoside Drug Industry Chain Analysis
7.2 Aminoglycoside Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aminoglycoside Drug Production Mode & Process
7.4 Aminoglycoside Drug Sales and Marketing
7.4.1 Aminoglycoside Drug Sales Channels
7.4.2 Aminoglycoside Drug Distributors
7.5 Aminoglycoside Drug Customers
8 Aminoglycoside Drug Market Dynamics
8.1 Aminoglycoside Drug Industry Trends
8.2 Aminoglycoside Drug Market Drivers
8.3 Aminoglycoside Drug Market Challenges
8.4 Aminoglycoside Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Aminoglycoside Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Aminoglycoside Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Aminoglycoside Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Aminoglycoside Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Aminoglycoside Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Aminoglycoside Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Aminoglycoside Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Aminoglycoside Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Aminoglycoside Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Aminoglycoside Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aminoglycoside Drug, Product Type & Application
Table 12. Global Key Manufacturers of Aminoglycoside Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aminoglycoside Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycoside Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aminoglycoside Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Aminoglycoside Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Aminoglycoside Drug Sales Market Share by Region (2019-2024)
Table 19. Global Aminoglycoside Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Aminoglycoside Drug Sales Market Share by Region (2025-2030)
Table 21. Global Aminoglycoside Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Aminoglycoside Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Aminoglycoside Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Aminoglycoside Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Aminoglycoside Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Aminoglycoside Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Aminoglycoside Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Aminoglycoside Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Aminoglycoside Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Aminoglycoside Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Aminoglycoside Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Aminoglycoside Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Aminoglycoside Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Aminoglycoside Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Aminoglycoside Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Aminoglycoside Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Aminoglycoside Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Aminoglycoside Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Aminoglycoside Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Aminoglycoside Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Aminoglycoside Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Aminoglycoside Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Aminoglycoside Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Aminoglycoside Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Aminoglycoside Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Aminoglycoside Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Aminoglycoside Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Aminoglycoside Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Aminoglycoside Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Aminoglycoside Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Aminoglycoside Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Aminoglycoside Drug Sales Market Share by Type (2019-2024)
Table 53. Global Aminoglycoside Drug Sales Market Share by Type (2025-2030)
Table 54. Global Aminoglycoside Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Aminoglycoside Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Aminoglycoside Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Aminoglycoside Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Aminoglycoside Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Aminoglycoside Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Aminoglycoside Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Aminoglycoside Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Aminoglycoside Drug Sales Market Share by Application (2019-2024)
Table 63. Global Aminoglycoside Drug Sales Market Share by Application (2025-2030)
Table 64. Global Aminoglycoside Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Aminoglycoside Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Aminoglycoside Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Aminoglycoside Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Aminoglycoside Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Aminoglycoside Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Jemicare Corporation Information
Table 71. Jemicare Description and Business Overview
Table 72. Jemicare Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Jemicare Aminoglycoside Drug Product
Table 74. Jemicare Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Aminoglycoside Drug Product
Table 79. Teva Recent Developments/Updates
Table 80. Novartis Pharmaceuticals Corporation Information
Table 81. Novartis Pharmaceuticals Description and Business Overview
Table 82. Novartis Pharmaceuticals Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Pharmaceuticals Aminoglycoside Drug Product
Table 84. Novartis Pharmaceuticals Recent Developments/Updates
Table 85. Fangyuan-pharma Corporation Information
Table 86. Fangyuan-pharma Description and Business Overview
Table 87. Fangyuan-pharma Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Fangyuan-pharma Aminoglycoside Drug Product
Table 89. Fangyuan-pharma Recent Developments/Updates
Table 90. Aike Pharmaceutical Corporation Information
Table 91. Aike Pharmaceutical Description and Business Overview
Table 92. Aike Pharmaceutical Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Aike Pharmaceutical Aminoglycoside Drug Product
Table 94. Aike Pharmaceutical Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cipla Aminoglycoside Drug Product
Table 99. Cipla Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Pfizer Aminoglycoside Drug Product
Table 104. Pfizer Recent Developments/Updates
Table 105. FRESENIUS KABI Corporation Information
Table 106. FRESENIUS KABI Description and Business Overview
Table 107. FRESENIUS KABI Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. FRESENIUS KABI Aminoglycoside Drug Product
Table 109. FRESENIUS KABI Recent Developments/Updates
Table 110. Sun Pharma Corporation Information
Table 111. Sun Pharma Description and Business Overview
Table 112. Sun Pharma Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Sun Pharma Aminoglycoside Drug Product
Table 114. Sun Pharma Recent Developments/Updates
Table 115. Hikma Corporation Information
Table 116. Hikma Description and Business Overview
Table 117. Hikma Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Hikma Aminoglycoside Drug Product
Table 119. Hikma Recent Developments/Updates
Table 120. Lannett Company Corporation Information
Table 121. Lannett Company Description and Business Overview
Table 122. Lannett Company Aminoglycoside Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Lannett Company Aminoglycoside Drug Product
Table 124. Lannett Company Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Aminoglycoside Drug Distributors List
Table 128. Aminoglycoside Drug Customers List
Table 129. Aminoglycoside Drug Market Trends
Table 130. Aminoglycoside Drug Market Drivers
Table 131. Aminoglycoside Drug Market Challenges
Table 132. Aminoglycoside Drug Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aminoglycoside Drug
Figure 2. Global Aminoglycoside Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Aminoglycoside Drug Market Share by Type in 2023 & 2030
Figure 4. Neomycin Product Picture
Figure 5. Tobramycin Product Picture
Figure 6. Gentamicin Product Picture
Figure 7. Amikacin Product Picture
Figure 8. Etimicin Product Picture
Figure 9. Others Product Picture
Figure 10. Global Aminoglycoside Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Aminoglycoside Drug Market Share by Application in 2023 & 2030
Figure 12. Hospital
Figure 13. Retail Pharmacy
Figure 14. Others
Figure 15. Global Aminoglycoside Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Aminoglycoside Drug Market Size (2019-2030) & (US$ Million)
Figure 17. Global Aminoglycoside Drug Sales (2019-2030) & (K Units)
Figure 18. Global Aminoglycoside Drug Average Price (US$/Unit) & (2019-2030)
Figure 19. Aminoglycoside Drug Report Years Considered
Figure 20. Aminoglycoside Drug Sales Share by Manufacturers in 2023
Figure 21. Global Aminoglycoside Drug Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Aminoglycoside Drug Players: Market Share by Revenue in 2023
Figure 23. Aminoglycoside Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Aminoglycoside Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Aminoglycoside Drug Sales Market Share by Country (2019-2030)
Figure 26. North America Aminoglycoside Drug Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Aminoglycoside Drug Sales Market Share by Country (2019-2030)
Figure 30. Europe Aminoglycoside Drug Revenue Market Share by Country (2019-2030)
Figure 31. Germany Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Aminoglycoside Drug Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Aminoglycoside Drug Revenue Market Share by Region (2019-2030)
Figure 38. China Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Aminoglycoside Drug Sales Market Share by Country (2019-2030)
Figure 49. Latin America Aminoglycoside Drug Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Aminoglycoside Drug Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Aminoglycoside Drug Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. U.A.E Aminoglycoside Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Aminoglycoside Drug by Type (2019-2030)
Figure 59. Global Revenue Market Share of Aminoglycoside Drug by Type (2019-2030)
Figure 60. Global Aminoglycoside Drug Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Aminoglycoside Drug by Application (2019-2030)
Figure 62. Global Revenue Market Share of Aminoglycoside Drug by Application (2019-2030)
Figure 63. Global Aminoglycoside Drug Price (US$/Unit) by Application (2019-2030)
Figure 64. Aminoglycoside Drug Value Chain
Figure 65. Aminoglycoside Drug Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
